These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26849234)

  • 1. NMU signaling promotes endometrial cancer cell progression by modulating adhesion signaling.
    Lin TY; Wu FJ; Chang CL; Li Z; Luo CW
    Oncotarget; 2016 Mar; 7(9):10228-42. PubMed ID: 26849234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic features of neuromedin U in breast cancer are associated with NMUR2 expression involving crosstalk with members of the WNT signaling pathway.
    Garczyk S; Klotz N; Szczepanski S; Denecke B; Antonopoulos W; von Stillfried S; Knüchel R; Rose M; Dahl E
    Oncotarget; 2017 May; 8(22):36246-36265. PubMed ID: 28423716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying a Neuromedin U Receptor 2 Splice Variant and Determining Its Roles in the Regulation of Signaling and Tumorigenesis In Vitro.
    Lin TY; Huang WL; Lee WY; Luo CW
    PLoS One; 2015; 10(8):e0136836. PubMed ID: 26317338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian regulation of neuromedin U and its local actions in the ovary, mediated through neuromedin U receptor 2.
    Lin TY; Wu FJ; Lee WY; Hsiao CL; Luo CW
    Am J Physiol Endocrinol Metab; 2013 Apr; 304(8):E800-9. PubMed ID: 23423171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromedin U induces an invasive phenotype in CRC cells expressing the NMUR2 receptor.
    Przygodzka P; Sochacka E; Soboska K; Pacholczyk M; Papiewska-Pająk I; Przygodzki T; Płociński P; Ballet S; De Prins A; Boncela J
    J Exp Clin Cancer Res; 2021 Sep; 40(1):283. PubMed ID: 34493299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autocrine motility factor promotes endometrial cancer progression by targeting GPER-1.
    Li Y; Jia Y; Bian Y; Tong H; Qu J; Wang K; Wan XP
    Cell Commun Signal; 2019 Mar; 17(1):22. PubMed ID: 30836961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of neuromedin U type 1 receptor inhibits L-type Ca2+ channel currents via phosphatidylinositol 3-kinase-dependent protein kinase C epsilon pathway in mouse hippocampal neurons.
    Zhang Y; Jiang D; Zhang J; Wang F; Jiang X; Tao J
    Cell Signal; 2010 Nov; 22(11):1660-8. PubMed ID: 20599609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collagen triple helix repeat containing-1 promotes pancreatic cancer progression by regulating migration and adhesion of tumor cells.
    Park EH; Kim S; Jo JY; Kim SJ; Hwang Y; Kim JM; Song SY; Lee DK; Koh SS
    Carcinogenesis; 2013 Mar; 34(3):694-702. PubMed ID: 23222813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant Claudin-6-Adhesion Signaling Promotes Endometrial Cancer Progression via Estrogen Receptor α.
    Kojima M; Sugimoto K; Kobayashi M; Ichikawa-Tomikawa N; Kashiwagi K; Watanabe T; Soeda S; Fujimori K; Chiba H
    Mol Cancer Res; 2021 Jul; 19(7):1208-1220. PubMed ID: 33727343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuromedin U inhibits T-type Ca2+ channel currents and decreases membrane excitability in small dorsal root ganglia neurons in mice.
    Wang F; Zhang Y; Jiang X; Zhang Y; Zhang L; Gong S; Liu C; Zhou L; Tao J
    Cell Calcium; 2011 Jan; 49(1):12-22. PubMed ID: 21106238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enolase-1 is a therapeutic target in endometrial carcinoma.
    Zhao M; Fang W; Wang Y; Guo S; Shu L; Wang L; Chen Y; Fu Q; Liu Y; Hua S; Fan Y; Liu Y; Deng X; Luo R; Mei Z; Jiang Q; Liu Z
    Oncotarget; 2015 Jun; 6(17):15610-27. PubMed ID: 25951350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuromedin U is regulated by the metastasis suppressor RhoGDI2 and is a novel promoter of tumor formation, lung metastasis and cancer cachexia.
    Wu Y; McRoberts K; Berr SS; Frierson HF; Conaway M; Theodorescu D
    Oncogene; 2007 Feb; 26(5):765-73. PubMed ID: 16878152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromedin U (NMU) regulates osteoblast differentiation and activity.
    Hsiao YT; Jestes KJ; Jackson KL; Zukosky T; Squire ME; Hum JM; Lowery JW
    Biochem Biophys Res Commun; 2020 Apr; 524(4):890-894. PubMed ID: 32057362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chondroitin sulfate proteoglycan protein is stimulated by interleukin 11 and promotes endometrial epithelial cancer cell proliferation and migration.
    Winship A; Van Sinderen M; Heffernan-Marks A; Dimitriadis E
    Int J Oncol; 2017 Mar; 50(3):798-804. PubMed ID: 28098860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and pharmacological characterization of a small-molecule antagonist at neuromedin U receptor NMUR2.
    Liu JJ; Payza K; Huang J; Liu R; Chen T; Coupal M; Laird JM; Cao CQ; Butterworth J; Lapointe S; Bayrakdarian M; Trivedi S; Bostwick JR
    J Pharmacol Exp Ther; 2009 Jul; 330(1):268-75. PubMed ID: 19369576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial membrane protein-2 promotes endometrial tumor formation through activation of FAK and Src.
    Fu M; Rao R; Sudhakar D; Hogue CP; Rutta Z; Morales S; Gordon LK; Braun J; Goodglick L; Wadehra M
    PLoS One; 2011; 6(5):e19945. PubMed ID: 21637765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neuropeptide neuromedin U promotes inflammation by direct activation of mast cells.
    Moriyama M; Sato T; Inoue H; Fukuyama S; Teranishi H; Kangawa K; Kano T; Yoshimura A; Kojima M
    J Exp Med; 2005 Jul; 202(2):217-24. PubMed ID: 16009716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and expression patterns of neuromedin U and its receptors in pigs.
    Li X; Niu M; Su J; Ma Z; Jin M; Qiao W; Zhang Y; Feng Y; An N; Hou Y; Yang S; Chuan S; Lei Z
    Neuropeptides; 2017 Aug; 64():47-60. PubMed ID: 28434792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of Cathepsin B suppresses the proliferation and invasion of endometrial cancer.
    Bao W; Fan Q; Luo X; Cheng WW; Wang YD; Li ZN; Chen XL; Wu D
    Oncol Rep; 2013 Aug; 30(2):723-30. PubMed ID: 23708264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of Rac and Rho signaling in cancer cell motility in 3D substrates.
    Yamazaki D; Kurisu S; Takenawa T
    Oncogene; 2009 Apr; 28(13):1570-83. PubMed ID: 19234490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.